PMID: 6479819Aug 30, 1984

Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors

Fortschritte der Medizin
V Wahn

Abstract

15 patients with different forms of relevant antibody deficiency syndromes were treated with gammaglobulin (Immunglobulin SRK) by intravenous route. Analysis of the complement system showed a weak activation of the C-system in vivo and a reduction of C-turnover. Prior to infusions C-turnover seemed to be increased pathoogically. In response to infusions a significant increase in immune complexes or immune complex-like material could be demonstrated, partly caused by "real" antigen-antibody-reactions and partly by the in vivo action of gammaglobulin aggregates. These "induced" immune complexes may have immunomodulatory effects. Three patients developed anaphylactic reactions to gammaglobulin. In one patient these were associated with a classical antigen-antibody reaction and complement activation, and in a second patient with a questionable antigen-antibody reaction and complement activation. A third patient had an anaphylactic reaction without any of these signs.

Related Concepts

Anaphylaxis
Immune complex
Autoantibodies
Hemolytic Complement
Polyglobin
Normal Serum Globulin Therapy
Immunoglobulins
Immunologic Deficiency Syndromes

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.